Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | P2RY10 | O00398 | 2/20 | 0.43 |
| ▸ | GPR174 | Q9BXC1 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9665651 | 0.98 | LMNA (0.50) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL598488 | 0.98 | LMNA (0.50) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL598288 | 0.98 | LMNA (0.50) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL599360 | 0.98 | LMNA (0.50) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL9664746 | 0.98 | LMNA (0.50) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL598299 | 0.98 | LMNA (0.50) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL29431881 | 0.97 | MAPT (0.49) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL598924 | 0.97 | MAPT (0.47) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL3283798 | 0.97 | MAPT (0.47) | MAPTLMNADGKAALDH1A1PAM | |
| SCHEMBL15649993 | 0.87 | LMNA (0.51) | MAPTLMNADGKAALDH1A1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108135962-A | For the pharmaceutical preparation of oral delivery peptide medicament | 塞浦路迈德有限责任公司 | 2018-06-08 | — | — | CN | claimed |
| CN-106794252-A | Pharmaceutical formulations for oral delivery of peptide or protein drugs | 塞浦路迈德有限责任公司 | 2017-05-31 | — | — | CN | claimed |
| CN-119156221-A | Improved oral pharmaceutical formulations of therapeutic peptides and proteins | 西普鲁梅有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-116669710-A | Compositions of peptide inhibitors of interleukin-23 receptor | 詹森药业有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-116419750-A | Improved pharmaceutical formulations of GLP-1 receptor agonists | 西普鲁梅有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-111971027-A | Oral formulations and treatments for parathyroid hormone analogs | 奥孟亚股份有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-108135962-A | For the pharmaceutical preparation of oral delivery peptide medicament | 塞浦路迈德有限责任公司 | 2018-06-08 | — | — | CN | disclosed |
| CN-106794252-A | Pharmaceutical formulations for oral delivery of peptide or protein drugs | 塞浦路迈德有限责任公司 | 2017-05-31 | — | — | CN | disclosed |
| CN-104955472-A | Fatty acid acylated amino acids for growth hormone delivery | NOVO NORDISK HEALTHCARE AG | 2015-09-30 | — | — | CN | disclosed |